Literature DB >> 18027103

Novel mutations in abetalipoproteinaemia and homozygous familial hypobetalipoproteinaemia.

R Vongsuvanh1, A J Hooper, J C Coakley, J S Macdessi, E V O'Loughlin, J R Burnett, K J Gaskin.   

Abstract

Abetalipoproteinaemia (ABL) and homozygous familial hypobetalipoproteinaemia (FHBL) are rare inherited disorders associated with low or undetectable levels of apolipoprotein B (apoB)-containing lipoproteins. Patients present with the symptoms and sequelae of fat malabsorption, including fat-soluble vitamin deficiencies. We describe two novel mutations: one an APOB gene mutation causing FHBL and the other a microsomal triglyceride transfer protein (MTP) gene mutation causing ABL. Two siblings of consanguineous parents were homozygous for an apoB mutation 4339delT causing an apoB-30.9 truncation. In another family, a boy born to consanguineous parents was homozygous for a 319 bp in-frame deletion of MTP exon 15 (c.2076-39_2303 + 52del319). All three children presented with malabsorption and liver dysfunction and had similar very low serum lipid, apoB, and fat-soluble vitamin levels. The FHBL parents had low serum lipid and apoB profiles distinguishing the disorder from the normal levels in ABL parents. Future patients presenting with FHBL or ABL should be genotyped to provide further insight into the varying clinical severity related to molecular heterogenicity in these two conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18027103     DOI: 10.1007/s10545-007-0693-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  4 in total

Review 1.  Diagnosis and management of familial dyslipoproteinemias.

Authors:  Peter O Kwiterovich
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

2.  Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases.

Authors:  Laurence Chardon; Agnès Sassolas; Bernard Dingeon; Laurence Michel-Calemard; Michel Bovier-Lapierre; Philippe Moulin; Alain Lachaux
Journal:  Eur J Pediatr       Date:  2008-12-09       Impact factor: 3.183

3.  Musings on genome medicine: cholesterol and coronary artery disease.

Authors:  David G Nathan; Stuart H Orkin
Journal:  Genome Med       Date:  2009-06-08       Impact factor: 11.117

Review 4.  Abetalipoproteinemia: two case reports and literature review.

Authors:  Rola Zamel; Razi Khan; Rebecca L Pollex; Robert A Hegele
Journal:  Orphanet J Rare Dis       Date:  2008-07-08       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.